In this podcast, Dr. Erica Mayer reviews research highlights from the San Antonio Breast Cancer Symposium. New insights into hormone therapy, targeted therapy, joint stiffness, and fertility preservation are covered.
In this Voices on Cancer post, patient advocate and breast cancer survivor Michael Singer discusses his efforts to raise awareness of breast cancer in men.
In this podcast, Dr. Noelle LoConte discusses a recent statement from the American Society of Clinical Oncology that covers the link between drinking alcohol and developing cancer.
Research Round Up Podcast: Managing Side Effects, Breast Cancer, Chronic Myeloid Leukemia, and Myeloma
Cancer.Net Associate Editors discuss exciting new cancer research in the final Research Round Up podcast of the summer.
In this Voices on Cancer post, patient advocate and author Andrea Hutton talks about how to use writing to share your cancer experience with others.
ASCO Annual Meeting 2017: Advances in Immunotherapy for Multiple Myeloma and Mesothelioma, and Targeted Therapies for Non-Small Cell Lung Cancer and HER2-Positive Breast Cancer
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer.
ASCO Annual Meeting 2017: Symptom Reporting Extends Lives, Shorter Chemotherapy for Some Colon Cancer Patients, and Targeted Therapy in BRCA-Related Breast Cancer
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
The reasons why some women experience a late recurrence of breast cancer are complex. In this post, Dr. Crystal Moore describes who may be at risk of late recurrence and 5 things you can do to thrive in your life and survivorship.
In this Voices on Cancer blog post, survivor Patty Spears discusses the role she has played on ASCO guideline panels and why having a patient’s voice there is so important.